Spasticity Stocks List
|ACOR||D||Acorda Therapeutics, Inc.||1.96|
|CNCE||F||Concert Pharmaceuticals, Inc.||1.76|
|FBT||F||First Trust Amex Biotech Index Fund||3.13|
|PBE||D||PowerShares Dynamic Biotech & Genome||2.71|
|SBIO||F||ALPS Medical Breakthroughs ETF||2.39|
|FTXH||D||First Trust Nasdaq Pharmaceuticals ETF||1.72|
|FTXN||C||First Trust Nasdaq Oil & Gas ETF||1.72|
View all Spasticity related ETFs...
Spasticity (from Greek spasmos- 'drawing, pulling') is a feature of altered skeletal muscle performance with a combination of paralysis, increased tendon reflex activity, and hypertonia. It is also colloquially referred to as an unusual "tightness", stiffness, or "pull" of muscles.
Clinically, spasticity results from the loss of inhibition of motor neurons, causing excessive velocity-dependent muscle contraction. This ultimately leads to hyperreflexia, an exaggerated deep tendon reflex. Spasticity is often treated with the drug baclofen, which acts as an agonist at GABA receptors, which are inhibitory.
Spastic cerebral palsy is the most common form of cerebral palsy, which is a group of permanent movement problems that do not get worse over time. GABA's inhibitory actions contribute to baclofen's efficacy as an anti-spasticity agent.